Bedford Research Foundation Hosts Ninth Annual Activated Egg Symposium
The Bedford Research Foundation is hosting the ninth annual Activated Egg Symposium, a yearly event that brings together experts in the stem cell research community to discuss their work, and form collaborations. The foundation's director, Dr. Ann Kiessling is proud to announce that this year's keynote speaker is Dr. Janet Rossant of the University of Toronto. The event is on November 4th, 2011 from 8am to 7:30pm.
The prestigious group includes internationally recognized researchers including Harvard Medical School’s Dr. Ann Kiessling who organized this year’s agenda. Kiessling is the winner of the 2009 Gabbay Award, 2011 CWU Alumni Achievement Award and UVA Alumni Achievement Award, in addition to writing the first text book on Stem Cells. Dr. Kiessling is also the director of the Bedford Stem Cell Research Foundation based in Somerville, MA.
This year’s keynote, Janet Rossant, Professor of Molecular Genetics, Obstetrics and Gynecology at the University of Toronto, and Chief of Research at the Hospital for Sick Children, will be presenting her talk "Manipulating the mouse embryo: from lineages to stem cells and back again." Professor Rossant is internationally recognized for her pioneering research in mouse genetics.
Rossant will be joined by internationally known leaders including, Dr. Rafael Fissore, Chair of Veterinary and Animal Sciences at the University of Massachusetts, Dr. Maya Mitalipova, Director of Whitehead Institute’s Stem Cell Facility at MIT, Dr. Laura Grabel, Wesleyan University, Dr. Dieter Egli from the New York Stem Cell Foundation, Dr. David Keefe, Chair of Ob/Gyn at New York University School of Medicine, and Chris Hempel the Founder of the Addi and Cassi Fund.
Dr. Kiessling says that this year’s group of presenters are among the most important scientists who have presented at the Symposium. Past Keynote speakers include Dr. Ian Wilmut, Dr. Ivar Mendez and Dr. Renee A. Reijo, Dr. Rudolph Jaenisch, George Daley, and Alan Trounson, all have presented their latest findings at the Activated Egg Symposium to the 100 opinion leading scientists in the country who attend annually.
This year’s discussions will include estimates of time to develop new stem cell based therapies for degenerative diseases, including diabetes, Parkinson’s disease, spinal cord diseases, AIDS and heart failure.
At this crucial time, when federal funding is not sufficient for the research necessary, the Bedford Stem Cell Research Foundation's Ninth Annual Activated Egg Symposium is bringing together an elite group of speakers from Connecticut, Massachusetts and California to share their latest research with other scientists, mostly funded by state stem cell research initiatives. The event provides a unique environment for investigators from academia, industry and infertility clinics to meet, discuss their most recent findings and form new collaborations.
Bedford Stem Cell Research Foundation is Massachusetts’ only independent, non-profit stem cell laboratory. www.bedfordresearch.org.
For further information, contact: email@example.com (617-281-7902) or firstname.lastname@example.org.